Many cancer drugs remain unproven 5 years after accelerated approval a study finds The Associated Press

Many cancer drugs remain unproven 5 years after accelerated approval a study finds  The Associated Press

The U.S. Food and Drug Administrations accelerated approval program is meant to give patients early access to promising drugs. But how often do these drugs actually improve or extend patients lives? … [+2916 chars]Read More

Leave a Reply

Your email address will not be published. Required fields are marked *